Dubai-UAE: Dubai Science Park (DSP), a holistic science-focused business community, has announced that it is leveraging its new built-to-suit model to construct a new Global Research Centre for Himalaya Drug Company, a world-leading producer of over 300 cosmetics, nutritional supplements, herbal medicines and pharmaceutical-grade Ayurvedic products in over 90 countries. Set to launch in 2021, the state-of-the-art facility aims to enhance Himalaya’s R&D capabilities at DSP to serve the GCC region.
Himalaya’s core business lies in R&D and manufacturing of high-quality pharmaceutical and personal care products for health-conscious consumers. The Himalaya Global Research Centre (HGRC) has been part of DSP’s eco-friendly Laboratory Complex since 2013, with product development, quality control and standardisation serving as priority areas of focus for the new facility.
The move, which will result in the creation of over 100 specialised jobs, aligns with the objective of the UAE Vision 2021 to shape a competitive knowledge economy. With Dubai emerging as a knowledge epicentre, overseas companies seeking to expand in the UAE and the wider region can benefit from the thriving innovative ecosystem that the emirate has to offer. Furthermore, Dubai has significantly improved its skill and talent score, attracting large numbers of professionals in diverse fields. The emirate’s vast talent pool will support Himalaya as it vies to develop pioneering herbal research and set industry trends in the region.
Marwan Abdulaziz Janahi, Managing Director of DSP and Chairing Member of the Pharmaceuticals and Medical Equipment Taskforce of the Dubai Industrial Strategy 2030, said: “In line with our ambition to consolidate Dubai’s position as a prime destination for scientific, R&D and manufacturing activities, we are pleased to support the expansion of Himalaya, a company dedicated to enhancing its expertise in the pharmaceutical and personal care fields.”
He added: “Over the last decade, the UAE and India have continued to strengthen their long-standing ties, evidenced by the significant number of Indian firms based in Dubai. Our robust infrastructure and business-friendly environment are among the key factors that encourage these companies to establish their Middle East head offices in the UAE.”
Meraj Manal, Chairman, Himalaya Global Holdings, said: “We aim to establish Himalaya as a science-based, problem solving, head to heel brand, not only within Dubai but within the wider GCC region and surrounding international markets. Himalaya invests in markets with an in-depth and long-term approach, maintaining high ethical standards at each step of the way. The UAE is positioned as a perfect place for us to initiate this expansion.”
Neil Cabral, Executive Director of Himalaya Global LTD and CEO of the Single Family Office, said: “Himalaya is firmly committed to upholding high ethical standards of research. Dubai’s capacity to attract skilled and talented people will enable the new HGRC complex to evolve into a global think tank and boost its success in setting future trends in herbal research as well as in launching innovative and internationally competitive products. The opening of the Centre will represent an important milestone in advancing our vision of ‘Wellness in Every Home, Happiness in Every Heart’.”
He added: “DSP’s collaborative environment acts as a hub where companies can innovate and grow. It supports leaders in science, R&D, and business by providing unique facilities in a prime location that cater to industry needs. With Dubai’s business-friendly government policies and smart infrastructure, we are confident that this innovative ecosystem will give us the tools to reach new heights.”
Himalaya’s research-driven mandate endeavours to bring a global perspective to its core operations through the study and research of worldwide healthcare trends. Over the last 88 years, the company has been a leader in the research and manufacturing of pharmaceutical, personal care, baby care, nutritional and animal health products. Steering away from ‘borrowed science’ – the practice of using published literature to substantiate efficacy claims, each Himalaya product undergoes years of primary research and clinical trials before it reaches the market.
Currently home to over 350 business partners with more than 4,000 employees, DSP’s vibrant business community continues to attract leading international companies within the science sector. The ongoing expansion of Himalaya is yet another example of DSP’s sustained support for its stakeholders.
-Ends-
About Dubai Science Park
Founded in 2005, Dubai Science Park (DSP) is a vibrant, holistic community dedicated to supporting entrepreneurs, SMEs and MNEs active in the sciences, energy and environmental sectors. With its ample office and laboratory space and robust infrastructure, DSP has created an enabling science-focused ecosystem that is home to more than 350 companies, employing over 3,600 professionals.
Through fostering growth, creativity, research and innovation in the areas of human science, plant science, material science, environmental science and energy science, DSP aims to play a significant role in facilitating a more sustainable and self-sufficient future that maximises the use of indigenous resources and talent.
For more information, please visit www.dsp.ae
For media inquiries, please contact:
Grace Borsellino
APCO Worldwide
Tel: +971 56 780 2691
Email: gborsellino@apcoworldwide.com
Imaan Jooma
APCO Worldwide
Tel: +971 52 671 0528
Email: ijooma@apcoworldwide.com
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
